Career Over 50

Business

Twist Bioscience Powers Ahead: Q1 2026 Revenue Jumps 17%, Fueled by AI-Driven Discovery Boom

Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.

Feb 2, 2026

Business

Canfor Insiders Show Confidence with Sustained Share Purchases Over Past Year

Insiders at Canadian forestry giant Canfor Corporation have been net buyers of the company's shares over the last twelve months, with President Susan Yurkovich leading the activity. The trend signals internal optimism as key executives invest personal capital even above current trading prices.

Feb 2, 2026

US

Congress Returns to Washington in Race Against Clock to Avert Government Shutdown

Lawmakers reconvene Monday as House GOP leadership pushes for rapid passage of a stopgap funding bill to prevent a prolonged partial government shutdown, with tensions high over border security provisions.

Feb 2, 2026

US

Government Shutdown Looms, Grammys Spotlight Immigration as Protests Sweep Nation

A partial government shutdown triggers furloughs, the Grammys become a platform for political statements, and nationwide protests over immigration policy unfold amid a severe winter storm's aftermath.

Feb 2, 2026

World

Syrian Government Troops Advance on Kurdish-Held Hasakah Under Fragile U.S.-Brokered Truce

A convoy of Syrian government forces was observed moving toward the strategic northeastern city of Hasakah on Monday, implementing a ceasefire agreement that aims to reintegrate Kurdish-administered territories with Damascus.

Feb 2, 2026

Business

Medicare's Obesity Drug Coverage Set to Fuel Lilly's Weight-Loss Pill Launch, CEO Says

Eli Lilly's CEO sees Medicare's new policy covering obesity treatments as a pivotal moment, poised to unlock access for millions of beneficiaries to its incoming oral drug, orforglipron, and intensify the market battle with Novo Nordisk.

Feb 2, 2026

Business

Beyond the Benchmark: Two S&P 500 Stocks with Momentum and One Facing Headwinds

The S&P 500 is home to market leaders, but not all its constituents are created equal. We examine one company navigating challenges and two others positioned for potential growth, providing context on their valuations and market positions.

Feb 2, 2026

Business

Mercantile Bank Delivers Stellar 117% Total Return to Shareholders Over Five Years, Outpacing Market

While recent performance has moderated, Mercantile Bank Corporation (NASDAQ:MBWM) has rewarded long-term investors with a total shareholder return more than double the broader market's gains over the past half-decade, driven by consistent earnings growth and dividends.

Feb 2, 2026

Business

JAKKS Pacific Delivers 17% Annual Returns Over Five Years, Outpacing Broader Market

Despite a recent pullback, shareholders in toy and consumer products maker JAKKS Pacific have seen robust long-term gains, with a total shareholder return of 118% over the past five years, fueled by a turnaround to profitability and strategic insider confidence.

Feb 2, 2026

Business

AutoNation Slashes 3,500 Jobs in Permanent Restructuring, Signaling Deeper Cost-Cutting Drive

AutoNation's move to permanently eliminate 3,500 positions marks a decisive shift in its operational strategy, raising critical questions for investors about cost efficiency, debt sustainability, and the long-term resilience of the auto retail business model.

Feb 2, 2026

World

Hungary's Opposition Tisza Holds Steady Lead Over Orban's Fidesz Ahead of Pivotal April Election

A new poll shows the centre-right Tisza party maintaining an eight-point advantage over the ruling Fidesz, setting the stage for Hungary's most consequential vote in over a decade, with major implications for Europe's political landscape.

Feb 2, 2026

Business

Capgemini Sells U.S. Government Arm, Citing Regulatory Hurdles and Strategic Misalignment

French IT giant Capgemini initiates the sale of its U.S. federal subsidiary, Capgemini Government Solutions, attributing the move to restrictive oversight rules for classified contracts and a desire for strategic focus.

Feb 2, 2026

Business

SEC and CFTC Forge Unified Front with 'Project Crypto' to Streamline Digital Asset Oversight

In a landmark move to end regulatory ambiguity, the SEC and CFTC have formally merged their 'Project Crypto' into a single rulebook. The joint initiative aims to harmonize federal oversight of crypto markets, drawing clearer lines between securities and commodities as legislative efforts advance in Congress.

Feb 2, 2026

World

India Overhauls Tax Rules to Propel Homegrown Accounting Firms onto World Stage

In a bid to boost the global competitiveness of Indian accounting and advisory firms, the government has announced a dual-pronged reform: simplifying the 'accountant' definition under Safe Harbour Rules and merging tax computation standards with financial reporting norms.

Feb 2, 2026

Business

New Gold Shareholders Greenlight Coeur Mining Takeover, Forging a North American Precious Metals Powerhouse

New Gold Inc. shareholders have overwhelmingly approved the planned acquisition by Coeur Mining, a move set to create a leading, diversified precious metals producer focused entirely in North America. The deal, valued through a share swap, is anticipated to close in mid-2026.

Feb 2, 2026

Business

Mizuho Bullish on Erasca, Initiates Coverage with $16 Target Amid RAS Inhibitor Progress

Erasca (ERAS) gains significant analyst momentum as Mizuho initiates coverage with an 'Outperform' rating and a $16 price target, citing confidence in its 2026 proof-of-concept milestones for RAS-targeted cancer therapies.

Feb 2, 2026

Business

ABIVAX Shares Surge on Takeover Buzz and Pipeline Progress, Despite CEO Denials

ABIVAX (NASDAQ:ABVX) shares have skyrocketed over 2000% in recent months, fueled by speculation of an Eli Lilly buyout and promising clinical data for its lead drug. CEO Marc De Garidel has publicly dismissed the acquisition rumors as 'noise,' redirecting focus to the company's financing needs and advancing therapeutic programs.

Feb 2, 2026

Business

Oracle Bets Big on AI Boom, Plans $50 Billion Cloud Infrastructure Push

Oracle Corporation announced a massive $45-50 billion fundraising plan for 2026, aiming to aggressively expand its cloud infrastructure to meet surging demand from leading AI and tech giants.

Feb 2, 2026

World

Europe's $955 Billion Recovery Fund Faces Uphill Battle to Deliver Lasting Economic Transformation

As the EU's landmark 'Next Generation' fund nears its final payout deadlines, its ambitious goal of modernizing the bloc's economy is being hampered by bureaucracy, skills gaps, and questions over long-term sustainability, despite pockets of innovation.

Feb 2, 2026

Business

Palantir Cements AI Ambitions with Major Korean Industrial Deal and European Sovereign AI Infrastructure Project

Palantir Technologies expands its strategic footprint in Asia through a deepened partnership with HD Hyundai, while securing a pivotal role in building sovereign AI data centers across Europe, the Middle East, and Africa with Sovereign AI and Accenture.

Feb 2, 2026